While 2-FaraA did not increase MYC levels in our experiments, the sustained MYC levels observed (Figure 4) could mediate apoptosis resistance in p53-negative MEC1 CLL cells. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.